ARDS - Nursing Case Study

Pathophysiology

• Primary mechanism: Inflammatory response - ARDS begins with an intense inflammatory reaction in the lungs, often triggered by direct lung injury (e.g., pneumonia) or indirect injury (e.g., sepsis). This leads to the release of cytokines and other inflammatory mediators, causing increased permeability of the alveolar-capillary membrane.

• Secondary mechanism: Alveolar-capillary barrier disruption - The increased permeability allows fluid, proteins, and inflammatory cells to leak into the alveoli, resulting in pulmonary edema and impaired gas exchange. This barrier disruption is crucial in the development of widespread alveolar collapse (atelectasis).

• Key complication: Impaired oxygenation - The fluid-filled and collapsed alveoli significantly reduce the lung's ability to oxygenate blood, leading to severe hypoxemia. This can result in respiratory failure if not promptly managed, highlighting the critical need for supportive care and oxygen therapy.

Patient Profile

Demographics:

56-year-old male, construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Smoking history (20 pack-years)

• Current medications: Lisinopril, Metformin, Atorvastatin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Shortness of breath and persistent cough

• Key symptoms: Rapid breathing, chest discomfort, fatigue, low-grade fever

• Vital signs: Temperature 38.2°C, Heart rate 110 bpm, Respiratory rate 28 breaths per minute, Blood pressure 140/85 mmHg, Oxygen saturation 88% on room air

Section 1

As the medical team continues to monitor the patient, his condition begins to exhibit signs of deterioration, indicating a change in patient status. Despite being placed on supplemental oxygen, his oxygen saturation remains concerningly low, fluctuating between 85% and 88% on 4L/min via nasal cannula. His respiratory distress becomes more pronounced, characterized by increased use of accessory muscles and intercostal retractions. Auscultation of the lungs reveals diffuse crackles bilaterally, indicative of worsening pulmonary edema. The patient's heart rate remains elevated at 118 bpm, and his respiratory rate has increased to 32 breaths per minute, suggesting a compensatory response to hypoxemia and respiratory distress.

Laboratory results return, revealing further insights into the patient's deteriorating condition. Arterial blood gas analysis shows a pH of 7.32, PaCO2 of 50 mmHg, PaO2 of 55 mmHg, and HCO3- of 24 mEq/L, indicating acute respiratory acidosis with severe hypoxemia. The elevated PaCO2 and decreased pH suggest that the patient is beginning to tire and is unable to adequately ventilate, leading to carbon dioxide retention. Additionally, his white blood cell count is elevated at 15,000 cells/mm³ with a left shift, supporting the presence of an ongoing inflammatory or infectious process, potentially exacerbating his ARDS.

Given these findings, the medical team recognizes the urgent need to escalate care. A decision is made to transfer the patient to the intensive care unit for closer monitoring and potential initiation of mechanical ventilation to improve oxygenation and support his failing respiratory effort. This intervention requires careful consideration of ventilator settings to prevent further lung injury while optimizing gas exchange. The team prepares to discuss these changes with the patient and his family, emphasizing the critical nature of his condition and the need for intensive supportive measures.

Section 2

As the patient is transferred to the intensive care unit, the medical team quickly implements a plan to initiate mechanical ventilation. Once intubated, the patient is placed on a volume-controlled ventilation mode to ensure adequate tidal volumes while minimizing the risk of barotrauma. Initial ventilator settings include a tidal volume of 6 mL/kg of predicted body weight, a positive end-expiratory pressure (PEEP) of 10 cm H2O, and a fraction of inspired oxygen (FiO2) of 60%. Despite these interventions, the patient's oxygen saturation remains suboptimal at 90%, prompting the team to cautiously increase the FiO2 to 80% and adjust the PEEP to 12 cm H2O.

Concurrent with the initiation of mechanical ventilation, the team reassesses the patient's hemodynamic status. An arterial line is placed to provide continuous blood pressure monitoring and facilitate frequent arterial blood gas sampling. Notably, the patient's blood pressure has decreased to 90/60 mmHg, likely secondary to increased intrathoracic pressure from the PEEP and potential sedation effects. Intravenous fluids are administered cautiously to improve perfusion without exacerbating pulmonary edema. Repeat arterial blood gases show a slight improvement with a pH of 7.34, PaCO2 of 48 mmHg, and PaO2 of 65 mmHg, indicating partial correction of the respiratory acidosis and improved oxygenation.

Despite these adjustments, the patient's condition remains precarious. A new complication arises as the patient develops signs of acute kidney injury, evidenced by elevated serum creatinine levels at 2.1 mg/dL, up from 1.0 mg/dL on admission. Urine output has decreased to less than 20 mL/hour, raising concerns about potential acute tubular necrosis related to hypoperfusion. The team must now balance aggressive management of the patient's respiratory status with supportive measures to protect renal function, all while addressing the underlying inflammatory or infectious process contributing to his ARDS. This complex interplay of systems requires ongoing monitoring and judicious clinical reasoning to optimize patient outcomes.

Section 3

As the ICU team continues to manage the patient's complex condition, a new diagnostic result emerges that offers insights into the underlying cause of the ARDS. A bronchoalveolar lavage performed shortly after intubation returns positive for pseudomonas aeruginosa, indicating a severe bacterial pneumonia as the precipitating factor. This finding prompts an urgent revision of the patient's antimicrobial regimen. The patient is already on broad-spectrum antibiotics, but based on the culture results, the team opts to initiate a more targeted therapy with piperacillin-tazobactam and ciprofloxacin to aggressively combat the identified pathogen.

Meanwhile, the patient's renal function is closely monitored due to the developing acute kidney injury. Serum creatinine continues to rise, now at 2.6 mg/dL, and electrolyte imbalances begin to manifest, with a potassium level of 5.8 mEq/L and a slightly elevated phosphate level. To address the potential for hyperkalemia-related cardiac issues, the team orders a continuous infusion of insulin and dextrose, along with calcium gluconate for cardiac membrane stabilization. Concurrently, nephrology is consulted to evaluate the need for potential renal replacement therapy if urine output does not improve with conservative measures.

The patient's hemodynamic status remains tenuous, with blood pressure fluctuating between 85/55 mmHg and 95/65 mmHg despite cautious fluid resuscitation. A vasopressor, norepinephrine, is initiated at a low dose to augment systemic vascular resistance and support organ perfusion. The team carefully titrates the vasopressor to maintain a mean arterial pressure above 65 mmHg, ensuring adequate perfusion to vital organs, including the kidneys. As these interventions unfold, the team remains vigilant for any signs of improvement or further deterioration, aware that the interplay of the respiratory, renal, and cardiovascular systems requires meticulous coordination and timely adjustments to the treatment plan.

Section 4

As the ICU team continues to monitor the patient, an acute change in status prompts immediate attention. The patient's respiratory condition suddenly deteriorates; the oxygen saturation drops to 82% despite being on 100% FiO2. The ventilator alarm indicates increased peak inspiratory pressures, suggesting worsening compliance of the lungs. Auscultation reveals diminished breath sounds bilaterally, raising concerns for potential pneumothorax or further consolidation. A stat chest X-ray is ordered to assess for any structural changes such as pneumothorax or pleural effusion that could be contributing to the sudden decline.

Simultaneously, the patient exhibits signs of increasing metabolic acidosis. Arterial blood gas analysis reveals a pH of 7.25, PaCO2 of 50 mmHg, and HCO3- of 18 mEq/L, indicating both respiratory and metabolic components. The team debates whether the worsening acidosis is primarily due to the respiratory deterioration or if the renal insufficiency is exacerbating the metabolic imbalance. The nephrologist suggests starting bicarbonate therapy cautiously to mitigate severe acidemia while reinforcing the need for potential renal replacement therapy if the patient's renal function and electrolyte balance do not stabilize.

In response to these developments, the team intensifies its focus on optimizing the patient's ventilatory support and reevaluating fluid management strategies to prevent further pulmonary edema. A decision is made to initiate continuous renal replacement therapy (CRRT) to better manage the patient's fluid balance and correct the metabolic derangements while avoiding further fluid overload. This integrated approach aims to stabilize the patient's condition and prevent further complications, underscoring the critical need for rapid clinical reasoning and coordinated care in managing this complex ARDS case.

Section 5

As the ICU team implements the continuous renal replacement therapy (CRRT), the patient's condition shows a mixed response. Over the next several hours, there is a modest improvement in the acid-base balance; repeat arterial blood gas analysis shows a pH of 7.30, PaCO2 of 48 mmHg, and HCO3- of 20 mEq/L. While these values suggest a slight correction in the metabolic acidosis, the patient's respiratory parameters remain concerning. Despite adjustments in ventilator settings, the oxygen saturation continues to hover around 84-86%, and peak inspiratory pressures remain elevated, indicating persistent poor lung compliance.

During the ongoing assessment, the new chest X-ray results arrive, revealing bilateral infiltrates consistent with worsening pulmonary edema, but no evidence of pneumothorax. This finding prompts the team to reassess the fluid management strategy. The decision is made to cautiously adjust diuretics in conjunction with CRRT to optimize fluid removal. Meanwhile, the patient develops hypotension with a blood pressure of 82/50 mmHg, requiring initiation of low-dose vasopressors to maintain adequate perfusion.

The sudden drop in blood pressure raises concerns about the possibility of septic shock or cardiogenic factors contributing to the patient's instability. The team orders a comprehensive set of cultures and a transthoracic echocardiogram to evaluate cardiac function and rule out new-onset heart failure. While awaiting further diagnostic results, the medical team remains vigilant, recognizing the need for continued multidisciplinary collaboration and vigilant monitoring to navigate this challenging phase of the patient's ARDS journey.